Investigator #168 — Louisville, Kentucky

Investigator #168 is a clinical research site located in Louisville, Kentucky, United States 40220.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator #168 has participated in 1 clinical trials.

Therapeutic areas: Kerato Conjunctivitis Sicca.

Sponsors: Kala Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Louisville

Browse all research sites in Kentucky · View every site in Louisville

• University of Louisville Pediatric Sleep Medicine Center
• University of Louisville 501 E. Broadway, Suite 210
• Norton Audubon Hospital-Norton Cancer Institute - Audubon ( Site 0105)
• University of Louisville Ambulatory Internal Medicine Resident Clinic
• University of Louisville Cancer Center
• University Neurologists PSC Pediatric Division
• University of Louisville 550 Clinic
• Norton Cancer Institute, Audubon Hospital Campus
• Kosair Children's Hospital
• (175) University Lousiville
• Department of Pediatric Critical Care, Kosair Children's Hospital
• Kosair Childrens Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator #168?

Investigator #168 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator #168 conducted?

Investigator #168 has 1 clinical trials on record. Their work covers Kerato Conjunctivitis Sicca.

Is Investigator #168 accredited by Crixeo Clinical Trials?

Investigator #168 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator #168?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.